## Core Concept
Tumor Lysis Syndrome (TLS) is a life-threatening complication that occurs when a large number of cancer cells die rapidly, releasing their contents into the bloodstream. This leads to several metabolic abnormalities. The key characteristics of TLS include hyperuricemia, hyperphosphatemia, hypocalcemia, and hyperkalemia.

## Why the Correct Answer is Right
The correct answer, , is associated with Tumor Lysis Syndrome because TLS is characterized by the rapid release of intracellular contents from lysed cancer cells. This results in elevated levels of uric acid (hyperuricemia), phosphate (hyperphosphatemia), and potassium (hyperkalemia) in the blood, along with decreased levels of calcium (hypocalcemia) due to calcium phosphate crystal formation.

## Why Each Wrong Option is Incorrect
- **Option A:** Hyperuricemia is a characteristic of TLS due to the breakdown of nucleic acids from lysed tumor cells into uric acid.
- **Option B:** Hyperphosphatemia occurs because tumor cells contain high levels of phosphate, which is released into the bloodstream upon cell lysis.
- **Option D:** Hyperkalemia is a feature of TLS as potassium is released from the lysed tumor cells.

## Clinical Pearl / High-Yield Fact
A key clinical pearl is that TLS is most commonly associated with cancers that have a high cell turnover rate, such as acute leukemias and lymphomas. Early recognition and aggressive management of TLS are crucial to prevent serious complications, including renal failure.

## Correct Answer Line
**Correct Answer: D. Hypoglycemia**.